Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory therapy after interventional radiology for HCC in cirrhotic patients
2016-004004-60Phase 2Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of etoricoxib in hepatocellular carcinoma (HCC) and Cirrhosis, sponsored by Humanitas Research Hospital. Primary endpoints: IL-6 serum level change at day 7 and HGF serum level change at day 7. Started Jan 2021; status: terminated.
02
Drugs
etoricoxib
03
Conditions
hepatocellular carcinoma (HCC)Cirrhosis
Beyond the preview
Go deeper on 2016-004004-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004004-60.